Pretty obvious the bulk of it would be legal costs. The company has to pay them and then endeavor to recover from their insurer, if able.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025